Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
CMRA Comera Life Sciences
1.400+0.050+3.70%
Trading Session
02/02 12:23 ET
High
1.400
Open
1.320
Turnover
39.41K
Low
1.300
Pre Close
1.350
Volume
29.61K
Intraday
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA) Sees Large Decline in Short Interest
Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA – Get Rating) was the target of a large drop in short interest during the month of December. As of December 30th, there was short interest totalling 1
12 Health Care Stocks Moving In Monday's Pre-Market Session
GainersShuttle Pharmaceuticals (NASDAQ:SHPH) stock increased by 41.8% to $2.51 during Monday's pre-market session. The company's market cap stands at $33.9 million. Jasper Therapeutics (NASDAQ:JSPR) s
12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersYield10 Bioscience (NASDAQ:YTEN) shares increased by 59.5% to $3.35 during Wednesday's after-market session. This security traded at a volume of 341.5K shares come close, making up 1423.5% of i
12 Health Care Stocks Moving In Monday's After-Market Session
GainersVYNE Therapeutics (NASDAQ:VYNE) shares rose 87.0% to $0.36 during Monday's after-market session. At the close, VYNE Therapeutics's trading volume reached 2.9 million shares. This is 590.3% of i
Comera Life Sciences And 1 Other Penny Stock Insiders Are Aggressively Buying
The Dow Jones closed higher by around 700 points on Friday following the release of jobs data for the month of December. When insiders purchase or sell shares, it indicates their confidence or concern
David Soane Acquires 202,701 Shares of Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA) Stock
Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA – Get Rating) major shareholder David Soane purchased 202,701 shares of the business's stock in a transaction dated Wednesday, January 4th. The shares
Insider Buy: Comera Life Sciences Holdings
01:08 PM EST, 01/06/2023 (MT Newswires) -- David Soane, 10% Owner, on January 04, 2023, executed a purchase for 202,701 shares in Comera Life Sciences Holdings (CMRA) for $249,322. Following the Form
Comera Life Sciences to Present at Upcoming Biotech Showcase Investor Conference
WOBURN, Mass., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA), a life sciences company developing a new generation of bio-innovative biologic medicines to improve patient delivery,
Short Interest in Comera Life Sciences Holdings, Inc. (NASDAQ:CMRAW) Drops By 46.0%
Comera Life Sciences Holdings, Inc. (NASDAQ:CMRAW – Get Rating) was the target of a significant drop in short interest in the month of December. As of December 15th, there was short interest totallin
Comera Life Sciences (NASDAQ:CMRA) Stock Price Up 1.6%
Shares of Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA – Get Rating) rose 1.6% on Thursday . The stock traded as high as $1.24 and last traded at $1.24. Approximately 20,126 shares were traded d
Company Overview
More
Comera Life Sciences Holdings, Inc. engages in developing medicines. It applies a deep knowledge of formulation science and technology to transform essential biologic medicines. The firm's approach is to provide patients with the freedom of self-injectable care, reduce institutional dependency and to put patients at the center of their treatment regimen. The company was founded on January 31, 2022 and is headquartered in Woburn, MA.
CEO： Mr. Jeffrey S. Hackman
Market： NASDAQ
Listing Date： 12/16/2020
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet